Rubberex secures shareholders' approval to buy Reszon Diagnostics for RM180mil


KUALA LUMPUR: Rubberex Corp (M) Bhd has obtained its shareholders' approval for the proposed acquisition of 100% equity interest in Reszon Diagnostics International Sdn Bhd for RM180mil.

Its shareholders also approved the proposed diversification into the healthcare business and proposed change of name to Hextar Healthcare Bhd.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Wasco to gain from transition to renewables
CPO prices to stay range-bound in February
Stiff competition to reshape auto landscape
Maybank’s sustained returns growth ambition
Steel Hawk unit secures Sabah contract
Real estate credit hits US$79bil in 4Q
Oxford Innotech wins RM4.8mil data centre job
MAG makes new executive leadership appointments
KIP-REIT expects higher traffic at its malls
Glovemakers shift focus as China floods markets

Others Also Read